Grundlæggende statistik
| CIK | 1058828 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Hypertension Diagnostics, Inc.
SEC Filings (Chronological Order)
Denne side giver en komplet, kronologisk liste over SEC-arkiveringer, eksklusive ejerskabsregistreringer, som vi leverer andre steder.
| February 13, 2020 |
HDII / Hypertension Diagnostics, Inc. CORRESP - - HYPERTENSION DIAGNOSTICS, INC. “HDII” 550 Highway 7 East, Unit 316 Ontario, Canada L4B3Z4 Re: Hypertension Diagnostics, Inc. Form 10K for the Fiscal Year Ended December 31, 2018 Filed September 18, 2019 File No. 000-24635 In response to the letter from the Securities and Exchange Commission, dated December 17, 2019. To: Securities and Exchange Commission, Hypertension Diagnostics Inc., and I, Lian |
|
| February 5, 2020 |
HDII / Hypertension Diagnostics, Inc. CORRESP - - HYPERTENSION DIAGNOSTICS, INC. "HDII" 550 Highway 7 East, Unit 316 Ontario, Canada L4B3Z4 RE: Hypertension Diagnostics, Inc. Form 10K for the Fiscal Year Ended December 31, 2018 Filed September 18, 2019 File No. 000-24635 In response to the letter from the Security Exchange Commission, dated December 17, 2019. To: Shareholders of Hypertension Diagnostics Inc., "HDII" and the Security Exchange Comm |
|
| January 17, 2020 |
HDII / Hypertension Diagnostics, Inc. RW - - REQUEST FOR WITHDRAWAL January 17, 2020 Securities and Exchange Commission 100 F Street NE Washington, DC 20549 RE: Application for Withdrawal of Registration Statement File No. |
|
| November 14, 2019 |
10-Q 1 hdii10q-093019.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or [] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission Fil |
|
| September 19, 2019 |
Quarterly Report - QTRLY REPORT FOR JUNE 30, 2019 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or [] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission File Number: 000-24635 Hypertension Diagnost |
|
| September 18, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018. or [] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission File Number: 000-24635 Hypertension Diagnostics |
|
| September 18, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 or [] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission File Number: 000-24635 Hypertension Diagnos |
|
| September 17, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017. or [] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission File Number: 000-24635 Hypertension Diagnostics |
|
| September 6, 2019 |
Changes in Control of Registrant, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 24, 2019 Hypertension Diagnostics, Inc. (Exact name of registrant as specified in its charter) Minnesota 000-24635 41-1618036 (State or other jurisdiction of incorporation) (Commi |
|
| June 11, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 0-24635 Hypertension Diagnostics, Inc. (Exact name of registrant as specifie |
|
| October 16, 2013 |
REVOLVING CONVERTIBLE PROMISSORY NOTE EX-10.2 3 v357389ex10-2.htm EXHIBIT 10.2 NEITHER THIS NOTE NOR THE SECURITIES THAT ARE ISSUABLE TO THE HOLDER UPON CONVERSION HEREOF (COLLECTIVELY, THE "SECURITIES") HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”), OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION. NEITHER THE SECURITIES NOR ANY INTEREST OR PARTICIPATION THEREIN MAY BE OFFERED FOR SALE, S |
|
| October 16, 2013 |
SECURITY AGREEMENT This SECURITY AGREEMENT, dated as of August 31, 2013 and effective as of October 10, 2013 (as amended, restated or modified from time to time, the “Security Agreement”), is executed by and between HDI PLASTICS, INC. |
|
| October 16, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 10, 2013 HYPERTENSION DIAGNOSTICS, INC. |
|
| October 16, 2013 |
SENIOR SECURED REVOLVING CREDIT FACILITY AGREEMENT IN THE AMOUNT OF US$3,000,000 BY AND AMONG HYPERTENSION DIAGNOSTICS, INC. |
|
| October 16, 2013 |
HYPERTENSION DIAGNOSTICS, INC. COMMON STOCK PURCHASE WARRANT NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS WARRANT NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. |
|
| October 16, 2013 |
GUARANTY AGREEMENT THIS GUARANTY AGREEMENT is dated as of August 31, 2013 and effective as of October 10, 2013 (as amended, restated or modified from time to time, the “Guaranty”), and is made by HDI PLASTICS, INC. |
|
| October 16, 2013 |
SECURITY AGREEMENT This SECURITY AGREEMENT, dated as of August 31, 2013 and effective as of October 10, 2013 (as amended, restated or modified from time to time, the “Security Agreement”), is executed by and between HYPERTENSION DIAGNOSTICS, INC. |
|
| September 18, 2013 |
8-K 1 v3553298k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 12, 2013 HYPERTENSION DIAGNOSTICS, INC. (Exact Name of Registrant as Specified in Charter) Minnesota (State or Other Jurisdiction of Incorporation |
|
| May 15, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2013 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-24635 HYPERTENSION DIAGNOSTICS, INC. |
|
| April 9, 2013 |
Other Events - CONVERTED BY EDGARWIZ Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 9, 2013 HYPERTENSION DIAGNOSTICS, INC. |
|
| February 7, 2013 |
EX-4 4 ex418k123112.htm CONVERTED BY EDGARWIZ |
|
| February 7, 2013 |
8-K 1 hdi8k20713.htm CONVERTED BY EDGARWIZ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 4, 2013 HYPERTENSION DIAGNOSTICS, INC. (Exact Name of Registrant as Specified in Charter) Minnesota (State or Other Jurisdiction of I |
|
| February 7, 2013 |
EX-4 3 ex428k20413.htm CONVERTED BY EDGARWIZ |
|
| February 7, 2013 |
EX-10 5 ex108k20413.htm CONVERTED BY EDGARWIZ |
|
| February 7, 2013 |
EX-4 2 ex438k20413.htm CONVERTED BY EDGARWIZ |
|
| January 3, 2013 |
Unregistered Sales of Equity Securities, Financial Statements and Exhibits - CONVERTED BY EDGARWIZ Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 2, 2013 HYPERTENSION DIAGNOSTICS, INC. |
|
| January 3, 2013 |
EX-10 3 ex101asherspa12312.htm CONVERTED BY EDGARWIZ SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of December 3, 2012, by and between HYPERTENSION DIAGNOSTICS, INC., a Minnesota corporation, with headquarters located at 10501 WAYZATA Boulevard - Suite 102, Minnetonka, MN 55305 (the “Company”), and ASHER ENTERPRISES, INC., a Delaware corporation, with |
|
| January 3, 2013 |
NEITHER THE ISSUANCE AND SALE OF EX-10 2 ex102ashernote12312.htm CONVERTED BY EDGARWIZ NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) |
|
| June 7, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 31, 2012 HYPERTENSION DIAGNOSTICS, INC. |
|
| April 3, 2012 |
UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 28, 2012 HYPERTENSION DIAGNOSTICS, INC. |
|
| February 21, 2012 |
Exhibit 99.1 Excluded Shares The filing of this report shall not be construed as an admission by the person identified in Item 2(a) that, for the purpose of Section 13(d) or 13(g) of the Securities Exchange Act, he is the "beneficial owner" of any equity securities listed below; and such person expressly disclaims that he is part of a "group" with the person listed below: Record Owner's Relationsh |
|
| February 21, 2012 |
HDII / Hypertension Diagnostics, Inc. / BRIMMER KENNETH WILLIAM - FORM SC 13D Activist Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ' 240. |
|
| February 14, 2012 |
HDII / Hypertension Diagnostics, Inc. / HOEKSTRA MARTEN Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information Statement Pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 3)* Hypertension Diagnostics, Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 44914V104 (CUSIP Number) December 31, 2011 Date of Event Which Requires Fi |
